Quantification of urinary 8-iso-PGF2α using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels
Authors:
- Amy K. SaengerASAmy K. Saenger
- Thomas J. LahaTLThomas J. Laha
- Michael J. EdenfieldMEMichael J. Edenfield
- Sayed M.H. SadrzadehSSSayed M.H. Sadrzadeh
- 1 November 2007
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 40 (16-17) , 1297-1304
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes MellitusCirculation, 2003
- Role of oxidative stress in atherosclerosisThe American Journal of Cardiology, 2003
- Plasma F2 IsoprostanesDiabetes Care, 2002
- Allergen-induced Synthesis of F2-Isoprostanes in Atopic Asthmatics: Evidence for Oxidant StressAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Quantification of the Major Urinary Metabolite of 15-F2t-Isoprostane (8-iso-PGF2α) by a Stable Isotope Dilution Mass Spectrometric AssayAnalytical Biochemistry, 1999
- In Vivo Formation of 8-Iso-Prostaglandin F2αand Platelet Activation in Diabetes MellitusCirculation, 1999
- A nomenclature system for the isoprostanesProstaglandins, 1997
- Measurement of urinary 8-epi-prostaglandin f2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokersFree Radical Biology and Medicine, 1996
- [16] Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism1994
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990